48 results
CORRESP
TEVA
Teva- Pharmaceutical Industries Ltd.
17 Apr 20
Correspondence with SEC
12:00am
in 42 CFR Part 403 (HHS/CMS Rule Re: Regulation to Require Drug Pricing Transparency) as follows: “Wholesale acquisition cost means, with respect
6-K
h8w7llxrsz
13 Jul 16
Current report (foreign)
12:00am
6-K
my71evwtiqd98
30 Nov 15
Current report (foreign)
12:00am
6-K
mnz w1j8d
31 Oct 13
Current report (foreign)
12:00am
6-K
w4nx4crf
2 May 13
Current report (foreign)
12:00am
6-K
petunuu0vpdjodc
1 Nov 12
Current report (foreign)
12:00am
6-K
gdz79
2 Aug 12
Current report (foreign)
12:00am
6-K
d4k1e5fyi80kd kodg
9 May 12
Current report (foreign)
12:00am
6-K
jt88vuo
2 Nov 11
Current report (foreign)
12:00am
6-K
fw5nsh8
28 Jul 11
Current report (foreign)
12:00am
6-K
cij1smqpxkdazkr1ko5
11 May 11
Current report (foreign)
12:00am
6-K
d9qhf9
11 May 11
Current report (foreign)
12:00am